BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692
73 results:

  • 1. The 'Other' subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma.
    Dong R; Wang Z; Cao D; Li Y; Fei Y; Gao P; Zhu M; Chen Z; Cai J; Zuo X
    IET Syst Biol; 2024 Feb; 18(1):23-39. PubMed ID: 38318939
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SOCS2 inhibits hepatoblastoma metastasis via downregulation of the JAK2/stat5 signal pathway.
    Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
    Sci Rep; 2023 Dec; 13(1):21814. PubMed ID: 38071211
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Unlocking the Potential: Novel NSAIDs Hybrids Unleash Chemopreventive Power toward liver cancer Cells through Nrf2, NF-κB, and MAPK Signaling Pathways.
    Narożna M; Krajka-Kuźniak V; Bednarczyk-Cwynar B; Baer-Dubowska W
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570726
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pan-cancer analysis of the oncogenic effects of G-protein-coupled receptor kinase-interacting protein-1 and validation on liver hepatocellular carcinoma.
    Wang T; Su K; Wang L; Shi Y; Niu Y; Zhou Y; Wang A; Wu T
    Adv Clin Exp Med; 2023 Oct; 32(10):1139-1147. PubMed ID: 36994687
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Down-regulation of hepatic expression of GHR/stat5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor.
    Abu El-Makarem MA; Kamel MF; Mohamed AA; Ali HA; Mohamed MR; Mohamed AEM; El-Said AM; Ameen MG; Hassnine AA; Hassan HA
    PLoS One; 2022; 17(11):e0277266. PubMed ID: 36374927
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/stat5 inhibition.
    Vesting AJ; Jais A; Klemm P; Steuernagel L; Wienand P; Fog-Tonnesen M; Hvid H; Schumacher AL; Kukat C; Nolte H; Georgomanolis T; Altmüller J; Pasparakis M; Schmidt A; Krüger M; Supprian MS; Waisman A; Straub BK; Raschzok N; Bernier M; Birkenfeld AL; Hövelmeyer N; Brüning JC; Wunderlich FT
    Mol Metab; 2022 Dec; 66():101626. PubMed ID: 36356831
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target.
    Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A
    Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
    Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
    J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
    Spohr C; Poggio T; Andrieux G; Schönberger K; Cabezas-Wallscheid N; Boerries M; Halbach S; Illert AL; Brummer T
    Leukemia; 2022 Apr; 36(4):970-982. PubMed ID: 34903841
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.
    Yi C; Chen L; Lin Z; Liu L; Shao W; Zhang R; Lin J; Zhang J; Zhu W; Jia H; Qin L; Lu L; Chen J
    Hepatology; 2021 Nov; 74(5):2544-2560. PubMed ID: 34036623
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. In Silico Validation, Fabrication and Evaluation of Nano-Liposomes of Bistorta amplexicaulis Extract for Improved Anticancer Activity Against Hepatoma Cell Line (HepG2).
    Batool S; Asad MJ; Arshad M; Ahmed W; Sohail MF; Abbasi SW; Ahmad S; Saleem RSZ; Ahmed MS
    Curr Drug Deliv; 2021; 18(7):922-934. PubMed ID: 33726649
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/stat5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
    Ramadan HK; Badr G; Ramadan NK; Sayed A
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circular RNA ZNF292 affects proliferation and apoptosis of hepatocellular carcinoma cells by regulating Wnt/β-catenin pathway.
    Chen CH; Su YJ; Ding H; Duan J; Wang J
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12124-12130. PubMed ID: 33336730
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The inhibition of IL-2/IL-2R gives rise to CD8
    Shi H; Wang W; Yin J; Ouyang Y; Pang L; Feng Y; Qiao L; Guo X; Shi H; Jin R; Chen D
    Cell Death Dis; 2020 Jun; 11(6):429. PubMed ID: 32513989
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast cancer Prognosis.
    Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
    J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hepatic Tumor Formation in Adult Mice Developmentally Exposed to Organotin.
    Katz TA; Grimm SL; Kaushal A; Dong J; Treviño LS; Jangid RK; Gaitán AV; Bertocchio JP; Guan Y; Robertson MJ; Cabrera RM; Finegold MJ; Foulds CE; Coarfa C; Walker CL
    Environ Health Perspect; 2020 Jan; 128(1):17010. PubMed ID: 31939706
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
    Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
    Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. mTOR direct crosstalk with stat5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
    Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
    Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.